AI-driven drug discovery, using LLMs and diffusion models, has improved drug design and reduced timelines. Although promising ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

FDA Launches Effort to Accelerate Drug Trials ...

OpenAI has expanded GPT-Rosalind, its frontier reasoning model series for life sciences research, genomics, and drug discovery, for eligible research organizations, adding two domain plugins and ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

HighRes® today announced a strategic collaboration to enable robotic capabilities on Waters Biosciences, formerly BD ...

A campaign for stronger online safety measures for children in the U.S. is gaining steam with recent jury verdicts against ...

New antibody technology improves RNA therapy delivery across the blood–brain barrier using engineered antibody targeting ...